TINA FLORES SCHECHINGER: Open Payments
NPI 1780632554 · CARROLL, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$591 in 31 payments from 10 companies in 2025. Trend: 2023 $261 · 2024 $288 · 2025 $591
Food & beverage: $591
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $112 |
| Novo Nordisk Inc | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Alexion Pharmaceuticals, Inc. | 2 | $37 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $32 |
| PFIZER INC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13 |
Products named: MOUNJARO, LEQVIO, Ozempic, KOSELUGO, JOURNAVX, JARDIANCE, PREVNAR 20, Wegovy.
Industry payments across IA — which companies pay providers there.
